Infectious Disease · Public Health · 2 h ago
New World screwworm reemergence highlights need for sustained control
This early-release perspective describes the New World screwworm’s spread from Panama in 2023 through Central America and Mexico, with animal cases reported in South Texas and New Mexico. The author argues that eradication requires ongoing surveillance, sterile-fly production and cross-border cooperation; the article is a personal reflection, not an outbreak investigation.
- Outbreak spread north from Panama beginning in 2023.
- Animal cases reported in South Texas and New Mexico.
- Sterile-fly production is part of a broader control effort.
- Perspective calls for sustained surveillance and cross-border cooperation.
In this perspective, a retired veterinary epidemiologist reviews the reemergence of New World screwworm (Cochliomyia hominivorax), a parasite eradicated from the United States decades ago. The author traces detections from Panama in 2023 through Central America and Mexico by late 2024, and describes animal cases in South Texas counties and New Mexico, involving cattle, sheep, a goat and a dog. A travel-associated human case was confirmed in Maryland in 2025; the article says no locally acquired human case had occurred in the United States as of August 2026.
The author emphasizes that larvae consume living tissue and that the fly can infest warm-blooded vertebrates, including people and wildlife. Control efforts include sterile-fly releases, surveillance, livestock movement screening and prompt care of wounds. A planned US Department of Agriculture facility in Texas aims eventually to produce up to 300 million sterile flies weekly; the author cites an estimated need of 500 million weekly to push the pest back to the Darién Gap, alongside planned production in Panama and Mexico.
The article argues that sterile-fly production alone is insufficient and calls for sustained funding and regional cooperation. As an early-release perspective, it offers the author’s interpretation rather than new primary data; outbreak counts and the facility’s production targets may change. The author reports no locally acquired US human cases through August 2026.
In practice
This perspective does not provide evidence for a change in clinical practice, but it highlights the possibility of human infestation during the ongoing regional outbreak. The author reports no locally acquired human cases in the United States through August 2026 and notes that exposure risk is concentrated among outdoor workers and people with open wounds or limited access to care. These statements are contextual, not new surveillance findings; the article supplies no clinical evaluation or treatment data.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Emerging Infectious Diseases: An Old Enemy Returns ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.